Clinical Trial: Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Nebulized Beclomethasone Dipropionate Improves Respiratory Lung Function in Preschool Children With Recurrent Wheezing

Brief Summary: This is a single-centre, open label study, aiming to evaluate the efficacy of beclomethasone dipropionate applied for 12 weeks with a dose of 400 µg twice a day (total dose 800 µg nebulized), on airway resistance and reactances (measured with Rint and FOT techniques) in children with recurrent wheezing, aged 2-5 years. In addition, clinic score as frequency of symptoms and exacerbations, will be assessed.

Detailed Summary:
Sponsor: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy

Current Primary Outcome: Lung fuction with Rint and FOT [ Time Frame: 12 Weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Istituto di Biomedicina e Immunologia Molecolare Alberto Monroy

Dates:
Date Received: February 12, 2015
Date Started: February 2015
Date Completion:
Last Updated: January 19, 2017
Last Verified: January 2017